| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |